Medline Inc. revenue by year
Over the 3 fiscal years shown, revenue went from $23.23B (year ended Dec 31, 2023) to $28.43B (year ended Dec 31, 2025), a compound annual growth rate of 10.6%. The fastest growth was +9.8% in the year ended Dec 31, 2024; the weakest year was +9.8% (year ended Dec 31, 2024).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $28.43B | — | Revenues | 10-K filed Feb 25, 2026 |
| Dec 31, 2024 | $25.51B | +9.8% | Revenues | 10-K filed Feb 25, 2026 |
| Dec 31, 2023 | $23.23B | — | Revenues | 10-K filed Feb 25, 2026 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Jun 27, 2026 | $7.68B | +11.6% | 10-Q filed Aug 5, 2026 |
| 3 months ended Mar 28, 2026 | $7.35B | +10.7% | 10-Q filed May 6, 2026 |
| 3 months ended Jun 28, 2025 | $6.89B | — | 10-Q filed Aug 5, 2026 |
| 3 months ended Mar 29, 2025 | $6.64B | — | 10-Q filed May 6, 2026 |
Source: SEC EDGAR XBRL company facts for CIK 2046386 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.